News & Insights - Aurevia

Supporting rapid site expansion across Europe

Written by Aurevia | 16 Nov 2026

An international pharmaceutical company needed to expand an ongoing multi-national clinical trial into several European countries. 

Aurevia supported the client with site identification, feasibility, and study start-up activities across multiple locations. With dedicated teams in Sweden, Finland, Germany, and Poland—combined with a broad network of clinical professionals across Europe—we enabled efficient site selection and activation. This allowed the client to scale their study footprint quickly while maintaining momentum in study execution. 

Learn more about our clinical operations.